Empire Life Investments Inc. Exact Sciences Corp Transaction History

Empire Life Investments Inc.

$1.6 Billion
Q3 2024

A detailed history of Empire Life Investments Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Empire Life Investments Inc. holds 248,698 shares of EXAS stock, worth $14.3 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

248,698

Previous 251,087 0.95%

Holding current value

$14.3 Million

Previous $10.6 Million 59.62%

% of portfolio

1.06%

Previous 0.67%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$42.43 - $70.83 $101,365 - $169,212	-2,389 Reduced 0.95%	248,698 $16.9 Million
Q2 2024 Jul 31, 2024	SELL	$41.33 - $74.26 $414,787 - $745,273	-10,036 Reduced 3.84%	251,087 $10.6 Million
Q1 2024 Apr 30, 2024	SELL	$56.27 - $73.77 $144,388 - $189,293	-2,566 Reduced 0.97%	261,123 $18 Million
Q4 2023 Feb 08, 2024	BUY	$59.06 - $75.72 $2.43 Million - $3.12 Million	41,174 Added 18.5%	263,689 $19.5 Million
Q3 2023 Nov 09, 2023	BUY	$65.94 - $99.04 $4.24 Million - $6.37 Million	64,301 Added 40.64%	222,515 $15.2 Million
Q2 2023 Aug 10, 2023	SELL	$62.68 - $95.05 $21,060 - $31,936	-336 Reduced 0.21%	158,214 $14.9 Million
Q1 2023 May 08, 2023	BUY	$47.19 - $70.77 $73,144 - $109,693	1,550 Added 0.99%	158,550 $10.8 Million
Q4 2022 Feb 02, 2023	SELL	$30.35 - $53.15 $52,444 - $91,843	-1,728 Reduced 1.09%	157,000 $7.77 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $166,467 - $257,069	5,207 Added 3.39%	158,728 $5.16 Million
Q2 2022 Aug 03, 2022	BUY	$35.61 - $76.23 $111,245 - $238,142	3,124 Added 2.08%	153,521 $6.05 Million
Q1 2022 May 11, 2022	BUY	$57.56 - $82.54 $1,496 - $2,146	26 Added 0.02%	150,397 $10.5 Million
Q4 2021 Feb 09, 2022	BUY	$72.5 - $100.68 $118,030 - $163,907	1,628 Added 1.09%	150,371 $11.7 Million
Q3 2021 Nov 09, 2021	BUY	$90.24 - $124.05 $129,313 - $177,763	1,433 Added 0.97%	148,743 $14.2 Million
Q2 2021 Aug 04, 2021	BUY	$93.66 - $139.27 $768,386 - $1.14 Million	8,204 Added 5.9%	147,310 $18.3 Million
Q1 2021 Apr 29, 2021	SELL	$116.57 - $155.01 $245,379 - $326,296	-2,105 Reduced 1.49%	139,106 $18.3 Million
Q4 2020 Feb 09, 2021	SELL	$99.61 - $142.12 $6.17 Million - $8.8 Million	-61,924 Reduced 30.48%	141,211 $18.7 Million
Q3 2020 Nov 05, 2020	BUY	$72.92 - $102.01 $45,866 - $64,164	629 Added 0.31%	203,135 $20.7 Million
Q2 2020 Aug 03, 2020	SELL	$55.75 - $92.75 $569,151 - $946,884	-10,209 Reduced 4.8%	202,506 $17.6 Million
Q1 2020 Apr 23, 2020	BUY	$37.9 - $104.44 $3.93 Million - $10.8 Million	103,755 Added 95.22%	212,715 $12.3 Million
Q4 2019 Jan 21, 2020	BUY	$77.66 - $99.74 $8.46 Million - $10.9 Million	108,960 New	108,960 $10.1 Million
Q2 2018 Aug 14, 2018	SELL	$37.84 - $69.96 $3.35 Million - $6.2 Million	-88,650 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$39.82 - $57.53 $3.53 Million - $5.1 Million	88,650 New	88,650 $3.58 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empire Life Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Empire Life Investments Inc. with notifications on news.

Account

Empire Life Investments Inc. Exact Sciences Corp Transaction History